[{"command":"settings","settings":{"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"nara_data_visualization":{"path":"modules\/nara\/nara_data_visualization"},"user":{"uid":0,"permissionsHash":"6f85937bd0020dcb3d29cf31b6d1e895e9c79d2b34b86a250f6aefd59aa5fbdb"}},"merge":true},{"command":"add_js","selector":"body","data":[{"src":"\/sites\/default\/files\/js\/js_2qQyUAgj1HGpPmjxn2dNAC2zpGhZp8fUqmWr3-mQI-I.js?scope=footer\u0026delta=0\u0026language=en\u0026theme=ford\u0026include=eJxLyy9KiU_LzEvJzEuPT8xMKdZPQxcBAPx5DgI"}]},{"command":"invoke","selector":null,"method":"naraFindingAidAdvBoxesUpdateHistory","args":["reset"]},{"command":"insert","method":"replaceWith","selector":"#finding-aid-boxes-list","data":"\u003Cdiv id=\u0022finding-aid-boxes-list\u0022\u003E\n\n\u003Cdiv class=\u0022nara-finding-aids-adv-boxes-folders\u0022\u003E\n \u003Cdiv class=\u0022usa-accordion\u0022 id=\u0022series-content-1221\u0022\u003E\n \u003Cp class=\u0022nara-finding-aids-adv-series-title\u0022\u003E\n \u003Cb\u003EGeneral Subject File, 1967-90.\u003C\/b\u003E\n \u003C\/p\u003E\n \n \u003Cdiv\u003E\n \u003Cdiv class=\u0022nara-finding-aids-adv-series\u0022\u003E\n \n (Boxes 1-96, 42 linear feet)\u003Cbr\/\u003E\n Memoranda, correspondence, reports, notes, press releases, manuals, pamphlets, periodicals, and clippings containing information on the drug approval process, drug safety, efficacy of approved drugs, food safety, and food and drug litigation compiled during his career at the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and in academia. Other topics include human subject research, drug and food labeling, self-medication, and carcinogenicity of food and drugs.\u003Cbr\/\u003E\n\u003Cbr\/\u003E\n Arranged alphabetically by subject.\n \n \u003C\/div\u003E\n \n \n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 1 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n A Plan for Action, Phase II - Food and Drug Administration - 5\/1987\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n A Tribute to Senator Lister Hill\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Abbreviated New Drug Application (ANDA)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Acupuncture\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Administration Drug Bill - 1977\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Advertising of OTC Drugs - Regulations (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Advertising of OTC Drugs - Regulations (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Advertising of OTC Drugs - Regulations (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Advisory Board Meeting - Center for the Study of Drug Development - 5\/16\/1983 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Advisory Board Meeting - Center for the Study of Drug Development - 5\/16\/1983 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Advisory Board Meeting-Center for the Study of Drug Development - Background Information - 5\/22\/1984 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Advisory Board Meeting - Center for the Study of Drug Development-Background Information - 5\/22\/1984 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Advisory Board Meeting - Center for the Study of Drug Development - May 31, 1985\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Advisory Board Meeting - Center for the Study of Drug Development - May 21, 1987 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Advisory Board Meeting - Center for the Study of Drug Development - May 21, 1987 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Advisory Board Meeting - Center for the Study of Drug Development - May 12, 1988 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 2 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Advisory Board Meeting - Center for the Study of Drug Development - May 12, 1988 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Advisory Board Meeting - Center for the Study of Drug Development - May 12, 1988 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Affidavit on Cyclamate (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Affidavit on Cyclamate (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Affidavit on Cyclamate (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Affidavit on Cyclamate-Toxicity Studies on Non-Nutritive Sweeteners (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Affidavit on Cyclamate-Toxicity Studies on Non-Nutritive Sweeteners (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Affidavit on OTC Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AIDS (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AIDS (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AIDS (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AIDS (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AIDS (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 3 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AIDS (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AIDS: Facts for Physicians - Illinois State Medical Society\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Alcohol Labeling\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Allera Analysis - Draft Letters\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n American Diets (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n American Diets (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n American Diets (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n American Diets (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n American Home Products Corporation, \u0026quot;Advil (Ibuprofen): Summary of Safety and Efficacy Data from the New Drug Application Requesting Advil (Ibuprofen) Be Approved for Non - Prescription Use\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n American Institute for Public Service\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n American Pharmaceutical Association Bicentennial Award for Distinguished Public Service - 4\/4\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS \u0026amp; Larkin - Encyclopedia Article 1980\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS Book Chapter\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS book chapter - \u0026quot;The Politics of Drug Regulation\u0026quot; (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS book chapter - \u0026quot;The Politics of Drug Regulation\u0026quot; (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 4 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS Information Mail\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS\/Dormann \ufffd 4 Seasons Hotel, Georgetown - 12\/11\/79, 4:00 pm\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS: Nutrition Today, \u0026quot;Dietary Goals for the United States\u0026quot; (comments)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS-Mike Wallace Letters-Dalcon Shield\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS-Personal Correspondence-1977 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS-Personal Correspondence-1977 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS-Personal Correspondence-1977 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS-Personal Correspondence-1979\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS-Personal Correspondence-1980\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS-Personal Correspondence-1981 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS-Personal Correspondence-1981 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS-Personal Correspondence-1983\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS-Personal Correspondence-1984\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS-Personal Correspondence-1985\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS-Personal Correspondence-1986\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS-Personal Correspondence-1987\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n ANDA Issue and the Future of the Hutt Draft (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n ANDA Issue and the Future of the Hutt Draft (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 5 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Animal Feed Products\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Animal Food Safety-Diethylstilbestrol (DES)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Annual Dinner of the White House Correspondents Association - May 3, 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Annual Dinner of the White House Correspondents Association - May 1, 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Annual Report - Center for the Study of Drug Development - 1981-1982\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Annual Report - Center for the Study of Drug Development - 1983-1984\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Annual Report - Center for the Study of Drug Development - 1984-1985\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Annual Report-Center for the Study of Drug Development - 1986-1987\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Annual Report - Food and Drug Administration - 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Annual Report - Food and Drug Administration - 1977\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Antibiotics in Animal Feed\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Article-Encyclopedia Britannica - Clinical Trials (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Article-Encyclopedia Britannica - Clinical Trials (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Article-Encyclopedia Britannica - Clinical Trials (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 6 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Animal Testing\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Antibiotics\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Cancer \/ Carcinogens \/ Cancer Research (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Cancer \/ Carcinogens \/ Cancer Research (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Consent\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Coronary Disease and Stroke\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - DNA Research\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Drug Advertising\/Sales\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Drug and Device Safety (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Drug and Device Safety (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Drug and Device Safety (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Drug and Device Safety (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Drug Approval Process \/ Drug Lag (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Drug Approval Process \/ Drug Lag (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Drug Industry\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 7 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Drug Labeling \/ Patient Packaging Inserts (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Drug Labeling \/ Patient Packaging Inserts (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Drug \/ Device \/ Food Litigation\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Educational Institutions \/ Grants\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Food and Cosmetic Safety (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Food and Cosmetic Safety (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Food and Cosmetic Safety (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Food Labeling\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Freedom of Information Act\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Healthcare\/Health Insurance\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - HEW \/ FDA - General (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - HEW \/ FDA - General (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - HEW \/ FDA-General (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - HEW \/ FDA - General (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 8 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - HEW \/ FDA - General (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Human Subject Research\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Miscellaneous Topics (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Miscellaneous Topics (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Nutrition\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Over the Counter \/ Self Medication\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Preventive Medicine \/ Vaccines\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Radiation \/ Nuclear Medicine\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Regulation \/ Regulatory Reform (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Regulation \/ Regulatory Reform (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Regulation \/ Regulatory Reform (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Research \/ Ethics (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Research \/ Ethics (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Research \/ Ethics (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Excerpts - Veterinary Medicine and Safety\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 9 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Speeches (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Articles and Speeches (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Aspen Institute of Humanistic Studies\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Association of Food and Drug Officials, Quarterly Bulletin, Vol. 49, No. 4, 10\/1985\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Association of Food and Drug Officials - Quarterly Bulletin\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Background for National Conference on Regulatory Reform (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Background for National Conference on Regulatory Reform (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Background for National Conference on Regulatory Reform (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Background for National Conference on Regulatory Reform (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Background for National Conference on Regulatory Reform (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Background for National Conference on Regulatory Reform (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Ballot: The Complete FDA - FY 92 Planning Process\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bazelon, David L. - \u0026quot;The Courts and the Public: Policy Decisions about High Technology and Risk\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 10 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Benefit \/ Risk\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Benefit \/ Risk-Benefit Risk Concept (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Benefit \/ Risk - Benefit Risk Concept (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Biomedical Research Brochure\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Blending - Executive Director of Regional Operations (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Blending - Executive Director of Regional Operations (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Blood Pressure\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Board of Directors - Cyanamid - Mexico \/ Canada - 10\/1981\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Book Chapter - Harvard (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Book Chapter-Harvard (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Brady, William T. - Food Law Institute, Inc.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Brief History of U.S. Food and Cosmetic Acts and Regulations Administered by FDA\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bristol-Myers\u0026#039; Consumer Guide to Product Information\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Britannica: Article-Risk \/ Benefit\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Brown, Michael S., Ph.D. - \u0026quot;Public Perception on Drug Risks\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BU Foods CV\u0026#039;s\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Burditt and Caulkins Deposition\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 11 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Biologics - Blood\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Biologics - Tony Morris (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Biologics - Tony Morris (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Biologics - Tony Morris (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Drugs - Direct Advertising of Rx Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Drugs - Direct Advertising of Rx Drugs (Empty)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Drugs - Direct Advertising of Rx Drugs-Rx Drug Ad. (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Drugs - Direct Advertising of Rx Drugs-Rx Drug Ad. (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Drugs - Direct Advertising of Rx Drugs-Rx Drug Ad. (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Drugs - Foreign Drug Study\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Drugs - Self Medication\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Veterinary Medicine (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Bureau of Veterinary Medicine (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Burros, Marian\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Animal Feed (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Animal Feed (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 12 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Animal Welfare\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - BF - Problem\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - GC - Problem\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Medicated Feed (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Medicated Feed (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Medicated Feed (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Medicated Feed - Antibacterials\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Medicated Feed - Antibiotics (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Medicated Feed - Antibiotics (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Residual Methodology (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Residual Methodology (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Review of Animal Drug Safety and Analytical Methodology - Cover Memo and Tab A\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Review of Animal Drug Safety and Analytical Methodology - Tabs B-C\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 13 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Review of Animal Drug Safety and Analytical Methodology - Tabs D-E\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Sensitivity of Method (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n BVM - Sensitivity of Method (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Calesa, Edward F.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n California Court Case - Lincosyn (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n California Court Case - Lincosyn (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cancer\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Carbadox\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Carcinogenesis (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Carcinogenesis (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Carcinogenesis (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Carcinogenesis (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 14 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Carcinogenesis (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Carcinogenesis (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Carcinogenesis (7)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cardiovascular Drugs (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cardiovascular Drugs (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cardiovascular Drugs - Beta Blockers\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Case materials in Food and Drug Law (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Case materials in Food and Drug Law (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Case materials in Food and Drug Law (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Case materials in Food and Drug Law (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Case materials in Food and Drug Law (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Case materials in Food and Drug Law (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Case materials in Food and Drug Law (7)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 15 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Center for the Study of Drug Development\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Center for the Study of Drug Development. \u0026quot;Clinical Research Practices and Drug Regulatory Affairs.\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Center for the Study of Drug Development-1985\/86 Annual Report\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Center for the Study of Drug Development - Advisory Board Meeting - May 14, 1981 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Center for the Study of Drug Development - Advisory Board Meeting - May 14, 1981 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Center for the Study of Drug Development - Brochure - Decennial Conference - 5\/28\/1986\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Center for the Study of Drug Development - General\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Chafetz, Morris E.-Writings\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Chapman, Carleton B., M.D. - \u0026quot;The Training of Medical Doctors\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Chloroflourocarbons \/ Flourocarbons\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Circulars - FDA (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Circulars - FDA (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Circulars - Industry (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Circulars - Industry (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Circulars - The NIH record\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 16 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Citizens Advisory Committee on the Food and Drug Administration - Report to the Secretary - 6\/1955\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Coffee\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n College of Medicine - Nutrition Education (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n College of Medicine - Nutrition Education (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n College of Medicine - Nutrition Education (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n College of Medicine - Nutrition Education (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Commission on the Federal Drug Approval Process\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Commissioner Schmidt\u0026#039;s Visit to FDA Region VI Dallas, Texas\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Commissioner Schmidt\u0026#039;s Visit to Region III - Philadelphia, Pennsylvania - November 7, 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 17 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Commissioner\u0026#039;s Report, October 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Commitment, Abbott Laboratories, Summer 1978\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 1st Committee Meeting - 10\/5-6\/1989 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 1st Committee Meeting - 10\/5-6\/1989 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 2nd Committee Meeting - 12\/5\/1989 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 2nd Committee Meeting - 12\/5\/1989 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 2nd Committee Meeting - 12\/5\/1989 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 2nd Committee Meeting - 12\/5\/1989 (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 18 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 3rd Committee Meeting - February 8-9, 1990 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 3rd Committee Meeting - February 8-9, 1990 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 3rd Committee Meeting - February 8-9, 1990 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 3rd Committee Meeting - February 8-9, 1990 (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 4th Committee Meeting - April 26-27, 1990 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 4th Committee Meeting - April 26-27, 1990 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 4th Committee Meeting - April 26-27, 1990 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 4th Committee Meeting - April 26-27, 1990 (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 4th Committee Meeting - April 26-27, 1990 (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 4th Committee Meeting - April 26-27, 1990 (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 4th Committee Meeting - April 26-27, 1990 (7)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 19 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 4th Committee Meeting - April 26-27, 1990 (8)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on Nutrition Components of Food Labeling - 4th Committee Meeting - April 26-27, 1990 - AMS\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Committee on the Nutrition Components of Food Labeling\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Common Sense Magazine, Vol. 10, No. 4, July\/August 1984\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Comparison of Costs of Major National Health Insurance Proposals (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Comparison of Costs of Major National Health Insurance Proposals (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Comparison of Costs of Major National Health Insurance Proposals (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Compilation of OTC Regulations - Updates - 5\/15\/1980\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Comptroller General of the United States, Report to Congress, \u0026quot;Assessment of the Food and Drug Administration\u0026#039;s Handling of Reports on Adverse Reactions from the Use of Drugs,\u0026quot; March 7, 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Comptroller General of the United States, Report to Congress, \u0026quot;How to Improve the Procurement and Supply of Drugs in the Federal Government,\u0026quot; December 6, 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Comptroller General of the United States, Report to the Subcommittee, \u0026quot;Supervision over Investigational Use of Selected Drugs,\u0026quot; July 23, 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Comptroller General of the United States. \u0026quot;Need to Resolve Safety Questions on Saccharin.\u0026quot; Washington, DC, 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Comptroller General of the United States. \u0026quot;Recalls of Large Volumes of Parenterals (Liquid Drugs Administered Intravenously or by Other Non-Oral Means).\u0026quot; Washington, DC, 1976.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Comptroller General of the United States. Report to Congress. \u0026quot;FDA Drug Approval - A Lengthy process that Delays the Availability of Important New Drugs.\u0026quot; Washington, DC, 1980.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 20 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Comptroller General of the United States. Report to Congress. \u0026quot;Federal Control of New Drug Testing is not Adequately Protecting Human Test Subjects and the Public.\u0026quot; Washington, DC, 1976.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Conference on Continuing Education for Physicians in the Use of Drugs -Proceedings-2\/5\/1969\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Conference on Continuing Education for Physicians in the Use of Drugs -Supplement to Proceedings - 2\/5\/1969\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Congressional Record, Vol. 120, No. 130, Part II, August 22, 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Consumer Issues\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Consumer Survival Kit - Maryland Center for Public Broadcasting\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cooper, Joseph D., ed. \u0026quot;Regulation, Economics, and Pharmaceutical Innovations: The Proceedings of the Second Seminar on Pharmaceutical Public Policy Issues,\u0026quot; American University, 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cooper, Theodore, M.D. - Asst. Secretary for Health, HEW\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 21 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (7)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (8)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (9)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (10)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (11)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (12)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 22 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (13)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (14)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (15)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (16)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (17)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (18)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (19)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (20)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 23 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (21)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence from the Commissioner (22)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence - FDA - 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence - FDA - 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence - FDA - 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence - FDA - 1976 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence - FDA - 1976 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence - FDA - 1976 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence - FDA - 1976 (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence - FDA - 1976 (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence - Post Government Service\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence - Pre Government Service\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 24 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence - Schmidt to Van Houweling\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Correspondence - Van Houweling to Schmidt\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cosmetics - A Pretty Mess (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cosmetics - A Pretty Mess (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cosmetics - A Pretty Mess (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cosmetics - A Pretty Mess (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Crout, J. Richard\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Crout, J. Richard, M.D. - New Drug Regulation and Its Impact on Innovation\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Crout, J. Richard, M.D. - Statement before the Subcommittee on Monopoly-11\/19\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Crout, J. Richard, M.D. - Transcript of Interview-David Susskind Show-1\/3\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cuatrecasas, Pedro - Contemporary Drug Development-Dilemmas\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Current Approaches towards Drug Regulation Reform - 10\/1982\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cutler v. Hayes - The Proprietary Association - 9\/9\/1982\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cyanamid\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cyanamid Canada Inc.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cyanamid Mr. A.M. Schmidt\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cyclamate - General (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 25 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cyclamate - General (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Cyclamate - General (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1976 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1976 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1977\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1979\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1980\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1981\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1982\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1983\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1984\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1985\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1986\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1988\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daily Clipping Service - FDA Press Office - 1989\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 26 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Dalkon Shield (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Dalkon Shield (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Dalkon Shield (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Dalkon Shield Problem (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Dalkon Shield Problem (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Dalkon Shield Problem (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daniels, Charles E. and Albert I. Wertheimer, Ph.D. - Therapeutic Significance of the United States \u0026quot;Drug Lag\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Debra A. and George Simon, et al v. G.D. Searle \u0026amp; Co.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Delaney Amendment - A Compendium of Relevant Information (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Delaney Amendment - A Compendium of Relevant Information (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Delaney Amendment - A Compendium of Relevant Information (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Delaney Amendment - A Compendium of Relevant Information (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Delaney Amendment - A Compendium of Relevant Information (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 27 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Delaney Clause (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Delaney Clause (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Department of Health, Education, and Welfare. Food and Drug Administration. \u0026quot;Holders of Approved Drug Applications for Drugs Presenting Actual or Potential Bioequivalence Problems.\u0026quot; Washington, DC, 1976.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Deregulation\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Deregulation-Reform\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Diethylstilbestrol (DES) - Hearings (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Diethylstilbestrol (DES) - Hearings (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Dialogues in Oral Contraception (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Dialogues in Oral Contraception (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Dialogues in Oral Contraception (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Diet and Cancer - What do we know?\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Diet - Diagnosis Related Groups (DRGs) - Nutrition Proposal\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Diethylstilbestrol (DES)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 28 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Dimethyl Sulfoxide (DMSO) as a Therapeutic Agent\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Dinner - Lancaster House-Tripartite Meeting on Health Matters - 3\/25\/1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Discussion of FDA Priorities for FY 1991-FDA Policy Board Alumni - 4\/1989\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Discussion of FDA Priorities - Ballot - FY 91 Planning Process\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Discussion of FDA Priorities - FDA Policy Board Alumni - 2\/1987\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Distribution of Medical Educational Material by Drug Companies\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n DNA (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n DNA (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n DNA NIH Guidelines\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Draft Report on Aspartame - Government Accountability Office\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Approval (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Approval (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Availability\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Bulletin Letters\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 29 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Conference - 5\/12\/1981\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Laws, Research, and Regulations (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Laws, Research, and Regulations (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Laws, Research, and Regulations (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Legislation (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Legislation (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Manufacturing\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Packaging\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Regulation Reform (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Regulation Reform (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Regulation Reform (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Regulation Reform (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 30 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Regulation Reform (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Research\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Research Board Meeting-2\/5\/1969\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Research Report - \u0026quot;The Blue Sheet\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Residue in Food of Animal Origin\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Safety - Bioavil\/Digoxin\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drug Safety - Tylenol\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs and Drug Regulation in the United States\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - AIDS (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - AIDS (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Bio-Availability (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Bio-Availability (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 31 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Bio-Availability (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Bio-Availability (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Bio-Availability (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Bio-Availability (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Bio-Availability (7)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Clinical Guidelines (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Clinical Guidelines (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Clinical Guidelines (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Clinical Guidelines (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Combo Policy\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Depo Provera (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 32 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Depo Provera (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - DES (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - DES (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Efficacy Study Implementation\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Discase (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Discase (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Discase (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Discase (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Compendium (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Compendium (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Compendium (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Compendium (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 33 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Fraud (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Fraud (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Fraud - Gerovital\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Fraud - Laetrile (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Fraud - Laetrile (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Fraud - Laetrile (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Fraud - Laetrile (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Fraud - Laetrile (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Lag (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Lag (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Lag (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Lag (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Lag (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 34 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Lag (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Lag (7)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Lag (8)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Listing \/ Labeling (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Listing \/ Labeling (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Safety (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Safety (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Safety - Adverse Reactions (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Safety - Adverse Reactions (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Safety - Adverse Reactions (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Safety - Adverse Reactions (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Safety - Adverse Reactions (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Safety - Adverse Reactions (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 35 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Safety - Diabetes\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Safety - Drug Firm Inspection Data\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Drug Use \/ Overuse\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Hypoglycemics (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Hypoglycemics (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Ibuprofen\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Ibuprofen - Arthritis Advisory Cmte. - 8\/18\/1983 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Ibuprofen - Arthritis Advisory Cmte. - 8\/18\/1983 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Ibuprofen - Arthritis Advisory Cmte. - 8\/18\/1983 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Ibuprofen - Arthritis Advisory Cmte. - 8\/18\/1983 (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Ibuprofen - Summary Basis for Approval\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - LVP (Large Volume Parenteral)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Medical Communication\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 36 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Names\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - OTC - Antacids (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - OTC - Antacids (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - OTC - Antacids (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - OTC - General (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - OTC - General (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - OTC - General (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - OTC - General (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - OTC - General (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - OTC - General (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - OTC - General (7)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - OTC - General (8)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 37 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - OTC - General (9)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Package Insert (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Package Insert (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Patents\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Patient Package Insert - PPI (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Patient Package Insert - PPI (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Patient Package Insert - PPI (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Patient Package Insert - PPI (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Prescribing\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Pricing (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Pricing (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Pricing (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 38 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Quality of Evidence\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Radioactive\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Regulation (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Regulation (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Regulation (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Regulation (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Regulation (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Regulation (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Regulation (7)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Regulation (8)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Regulation (9)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Risks\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Shortage\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Tissue Plasminogen Activator (TPA) - Hines Medical Society - 10\/8\/1987 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 39 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Tissue Plasminogen Activator (TPA) - Hines Medical Society - 10\/8\/1987 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Drugs - Tissue Plasminogen Activator (TPA) - Hines Medical Society - 10\/8\/1987 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n DuPont, Robert L., M.D. - \u0026quot;Science, Values, and the Marihuana Issue\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Early publications prior to FDA\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Economic Development\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Economic Priorities Report, Vol. 4, Nos. 4-5, Double Issue, August \/ November 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Editorial - Pharmaceutical Technology - 1982\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Effects of S. 2697 and S. 2697 on the FDA (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Effects of S. 2697 and S. 2697 on the FDA (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Effects of S. 2697 and S. 2697 on the FDA (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Energy - Misc.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Estrogen - Contraceptives (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Estrogen - Contraceptives (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Estrogen - Contraceptives (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Estrogen - Contraceptives (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 40 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Events Programs \/ Invitations \/ Certificates\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Executive Director of Regional Operations (EDRO)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Executive Information Manual - Food and Drug Administration (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Executive Information Manual - Food and Drug Administration (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Expert\u0026#039;s Shortened Version of Motion, Opposition, \u0026amp; Reply (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Expert\u0026#039;s Shortened Version of Motion, Opposition, \u0026amp; Reply (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Expert\u0026#039;s Shortened Version of Motion, Opposition, \u0026amp; Reply (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Facts about Alleged Revolving Door at FDA - 3\/11\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA 1978 Preliminary Budget\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Action Analysis\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Ad Hoc Science Advisory Committee - Report to the Commissioner\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA and Self-Medication\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA and the 94th Congress - Office of Legislative Services-12\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 41 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Annual Report 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Special Report, \u0026quot;From Test Tube to Patient: New Drug Development in the United States\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 6, No. 10, Dec. 1972 - Jan. 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 7, No. 6, July - August 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 7, No. 9, November 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 7, No. 10, Dec. 1973 - Jan. 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 8, No. 2, March 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 8, No. 4, May 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 8, No. 6, July - August 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 8, No. 9, November 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 8, No. 10, Dec. 1974 - Jan. 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 9, No. 1, February 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 9, No. 2, March 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 9, No. 3, April 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 9, No. 4, May 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 9, No. 7, September 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 9, No. 8, October 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 10, No. 1, February 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 10, No. 2, March 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 42 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 10, No. 5, June 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 10, No. 7, September 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 10, No. 9, November 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 11, No. 2, March 1977\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 12, No. 9, November 1978\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Consumer, Vol. 15, No. 5, June 1981\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Correspondence (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Correspondence (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Correspondence (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Correspondence (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Drug Bulletin (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 43 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Drug Bulletin (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Drug Bulletin Letters (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Drug Bulletin Letters (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Drug Bulletin Letters (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Drug Bulletin Letters (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Drug Statistical Handbook (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Drug Statistical Handbook (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Drug Statistical Handbook (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA History\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Legislative Proposals for FY 78 - 6\/3\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Organizational Chart-1990\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Regulations - Effect on Internists\/General Practitioners\/Psychiatrists Survey\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Regulations - Effects on Family Physicians\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Relationships and Communications with Industry\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA SRAF Book\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA Supplement to HEW Standards of Conduct - 1\/1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 44 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - 75th Anniversary\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - Benefit\/Risk\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - Budget\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - Budget \/ Administration (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - Budget \/ Administration (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - Budget \/Administration (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - Cancer \/ Carcinogenics\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - FY 77 Forward Plan\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - General\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - Industrial Relations in the Future\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - Industry Relations (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - Industry Relations (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - Industry Relations (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 45 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - Medical Reviewers Workshop [NAS-10M-Feb-3-4]\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA - Procedural Regulations\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA\u0026#039;s Regulation of Cancer Causing Substances and the Delaney Clause\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA\u0026#039;s Role in the Protection of Human Subjects\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDA\u0026#039;s Statement on FTC Rulemaking on OTC Drug Advertising\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDC [Food, Drug, and Cosmetics] Reports - \u0026quot;The Pink Sheet\u0026quot; - 1\/3\/1977\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDC Reports - \u0026quot;The Pink Sheet\u0026quot; - 1973\/74\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDC Reports - \u0026quot;The Pink Sheet\u0026quot; - 7\/13\/1981\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDC Reports - \u0026quot;The Pink Sheet\u0026quot; - 7\/21\/1980\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDC Reports - \u0026quot;The Pink Sheet\u0026quot; - August 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDC Reports - \u0026quot;The Pink Sheet\u0026quot; - January 1976 - May 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDC Reports - \u0026quot;The Pink Sheet\u0026quot; - June 1976 - July 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDC Reports - \u0026quot;The Pink Sheet\u0026quot; - September 1976 - November 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDLI [Food and Drug Law Institute] Book Article (Empty)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDLI Commemorative Book Committee (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDLI Commemorative Book Committee (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 46 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDLI Commemorative Book Committee (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDLI Commemorative Book Committee (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDLI Commemorative Book Committee (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDLI Commemorative Book Committee (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDLI Commemorative Book Committee (7)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDLI Panel - 10\/24\/1988\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDLI Project (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDLI Project (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDLI - 11\/28\/1988 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FDLI - 11\/28\/1988 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Food, Drug, and Cosmetic Act, as Amended, and Related Laws\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Food, Drug, and Cosmetic Act, As Amended - October 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 47 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Food, Drug, and Cosmetic Act (As Amended) - January 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Food, Drug, and Cosmetic Act, As Amended - October 1976 [Marked \u0026quot;A.M. Schmidt Work\u0026quot;]\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Food, Drug, and Cosmetic Act - As Amended - 1\/1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Register, Vol. 155, No. 139, 7\/19\/1990\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Register, Vol. 44, No. 166, 8\/24\/1976, pp. 49844-954 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Register, Vol. 44, No. 166, 8\/24\/1976, pp. 49844-954 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Register, Vol. 46, No. 233, 12\/4\/1981, pp. 59368-425\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Register, Vol. 47, No. 125, 6\/29\/1982 (Excerpts)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Register, Vol. 47, No. 132, 7\/9\/1982\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Register, Vol. 47, No. 134, 7\/13\/1982, pp. 30239-41 and 30293-5\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Register \/ Code of Federal Regulations\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Register - Over the Counter Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Regulation and Regulatory Reform, Chapter 8, Food and Drug Administration - 10\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Federal Regulations and Regulatory Reform - FDA\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 48 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Feingold, Ben F., M.D. (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Feingold, Ben F., M.D. (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Feingold, Ben F., M.D. (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Final Report on the National Commission on Product Safety - June 1970\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Finance Committee \u0026amp; Board of Directors Meetings - American Cyanamid Company - 10\/22\/1981 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Finance Committee \u0026amp; Board of Directors Meetings - American Cyanamid Company - 10\/22\/1981 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n First Annual David and Dorothy Gottlieb Memorial Lecture - October 3, 1979\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n First Status Report on the 18-Month Implementation - Bureau of Medical Devices and Diagnostic Products\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Additive Petition for Aspartame\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Administration\u0026#039;s Process for Approving New Drugs - Subcommittee Report - 11\/1980\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 49 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 1977 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 1977 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 1978\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 1979\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 1980\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 1981\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 1982\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 1983\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 1984\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 1985\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 1986\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 1987\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 28th Annual Educational Conference - 12\/11-12\/1984 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - 28th Annual Educational Conference - 12\/11-12\/1984 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - Board and Annual Meeting-December 1980 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - Board and Annual Meeting-December 1980 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - December 14, 1984\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - December 1986 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute - December 1986 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food and Drug Law Institute -Undated Materials\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 50 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Drug Cosmetics Law Journal\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Economics - Standards - Fortification\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Fortification - Guides - Comments (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Fortification - Guides - Comments (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Fortification - Guides - Comments (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Fortification - Guides - Comments (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Labeling (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Labeling (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Labeling (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Labeling (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Labeling (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 51 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Labeling (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Labeling (7)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Labeling - Committee (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Labeling - Committee (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Processing Magazine, January 1977\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety \/ Food Additives (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety \/ Food Additives (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety \/ Food Additives (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 52 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Aspartame (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Aspartame (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Aspartame (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Aspartame - Sweet versus Sour (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Aspartame - Sweet versus Sour (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Aspartame - Sweet versus Sour (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Cyclamates\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Cyclamates-Evaluation of Cyclamate Carcinogenicity\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Food Additive Program Meeting\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 53 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Iron (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Iron (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Saccharin (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Saccharin (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Saccharin (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Saccharin (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Saccharin (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Sugar\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Additives - Sweeteners\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Aerosol (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Aerosol (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Aerosol (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Asbestos (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Asbestos (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 54 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Chemicals (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Chemicals (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Chemicals (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Chemicals - Plastic Bottles\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - China\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Colors\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Colors - Red #2 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Colors - Red #2 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Colors - Red #4\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Fish\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Food Dyes\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Food Manufacturing\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Food Regulation\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 55 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Food Technology\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Generally Recognized as Safe\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Guidelines - General\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Heavy Metals\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Lead\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Meat Wrapper\u0026#039;s Asthma\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Mycotoxins\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Nitrite (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Nitrite (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Pasteurization\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Pesticides\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Salmonella\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Sanitation - Mushrooms\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Safety - Standards\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Service\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Supply - Future (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 56 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Supply - Future (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food, Drug, Cosmetic Law Journal, Vol. 33, No. 10, 10\/1978\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food - Health Food\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Foreword by AMS on Self-Medication - The Proprietary Association\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Fred Ross, Atty. - Re: Dr. Lagerson Case\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Freedom of Information\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n FY 1978 Legislative Proposals - 6\/25\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n G.D. Searle Cu-7 Cases - 5\/26\/1987\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Gardner, Sherwin - Speeches\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Gen. - Reprints (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Gen. - Reprints (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Generic Drugs (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Generic Drugs (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Generic Drugs (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 57 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Generic Drugs (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Generic Drugs (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Generic Drugs (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Gerovital H3\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Goyan, Jere E. - Commissioner of Food and Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Goyan, Jere E. - Swearing In Ceremony-11\/21\/1979\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n H.R. 11124 - \u0026quot;Medical Device Amendments of 1975\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n H.R. 11124 - \u0026quot;Medical Device Amendments of 1976\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n H.R. 5545 - \u0026quot;Medical Device Amendments of 1975\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hair\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hair Dye\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Harris, Patricia Roberts - Secretary, Department of Health, Education and Welfare\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hastings Center\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Health Care Practices and Perceptions - A Customer Survey of Self-Medication\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 58 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Health Label - Food\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Health Policy Institute. \u0026quot;Health Care Technology: Can We Decide What to Buy?\u0026quot; A Policy Monograph. Boston University: Boston, 1977.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Health Services - Professional Standards Review Organization\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Health Services - Quackery\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hearing Aids\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hearings before the Subcommittee on Health, Part 3 - \u0026quot;Health Care Crisis in America, 1971\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hearings before the Subcommittee on Health, Part 4 - \u0026quot;Health Care Crisis in America, 1971\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hearings before the Subcommittee on Health, Part 5 - \u0026quot;Health Care Crisis in America, 1971\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hearings before the Subcommittee on Intergovernmental Relations - \u0026quot;Establish a Senate Committee on Technology and the Human Environment\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hearings - Subcommittee on Nutrition (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hearings - Subcommittee on Nutrition (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 59 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Heart (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Heart (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Heart (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Herbs \/ Medicinal Plants\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Herder-Dorneich, Philipp. \u0026quot;The Economics of Self-Medication.\u0026quot; Edited by The German Proprietary Medicine Manufacturers Association. Geneva, 1977.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n HEW - General (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n HEW - General (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n HEW - General (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n HEW - General (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n HEW - NIH (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n HEW - NIH (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n HEW - Science and Public Policy (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n HEW - Science and Public Policy (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Histories of U.S. Food and Drug Law\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 60 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n History\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Holt Memorandum\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Human Experimentation\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hutt, Peter Barton - Regulating the Misbranding of Food\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hutt, Peter - The Future of the Food and Drug Administration\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Ibuprofen Tablets, 200 mg (OTC) - Summary of Pertinent Data on Safety and Efficacy - 8\/5\/1983 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Ibuprofen Tablets, 200 mg (OTC) - Summary of Pertinent Data on Safety and Efficacy - 8\/5\/1983 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Imminent Hazard\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Impact of Public Policy on Drug Innovation and Pricing - Seminar - 12\/15-16\/1975 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Impact of Public Policy on Drug Innovation and Pricing - Seminar - 12\/15-16\/1975 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Important Court Cases - Abbott Laboratories v. Harris, etc., et al. - 12\/21\/1979\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Important Court Cases - Appeal of Laetrile Decision - 8\/14\/1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Important Court Cases - Benylin Expectorant: Proposal to Deny Approval of Supplemental New Drug Application - 5\/31\/1978\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Important Court Cases - Center for Science in the Public Interest, et al. v. Dept. of the Treasury, et al. - 2\/9\/1983\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Important Court Cases - Freda McEwan v. Ortho Pharmaceutical Corp. and Syntex Laboratories, Inc. - 11\/15\/1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Important Court Cases - General\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Important Court Cases - Individual Criminal Liability under the FD\u0026amp;C Act - 7\/22\/1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 61 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Important Court Cases - Marshall, Secretary of Labor, et al. v. Barlow\u0026#039;s, Inc. - 5\/23\/1978\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Important Court Cases - Substantive Rulemaking Authority under Section 701(a) of the Act - 4\/19\/1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Important Court Cases-Vitamin A \u0026amp; D Case - 6\/7\/1977\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Index\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Influenza\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Institute of Medicine - Food Labels (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Institute of Medicine - Food Labels (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Institute of Medicine - Food, Background, Travel, Conflict of Interest (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Institute of Medicine - Food, Background, Travel, Conflict of Interest (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Institute of Medicine - Food, Background, Travel, Conflict of Interest (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Interim Reports and Staff Papers - Review Panel on New Drug Regulation - November 15, 1976 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Interim Reports and Staff Papers - Review Panel on New Drug Regulation - November 15, 1976 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Interim Reports and Staff Papers - Review Panel on New Drug Regulation - November 15, 1976 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Interim Reports and Staff Papers - Review Panel on New Drug Regulation - November 15, 1976 (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 62 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Intrauterine Devices - McCarthy v. G.D. Searle and Company Related Materials (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Intrauterine Devices - McCarthy v. G.D. Searle and Company Related Materials (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Intrauterine Devices - McCarthy v. G.D. Searle and Company Related Materials (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Introduction of Single Chemical Entities, Vol. I, the United States, 1941-1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Investigations and Reports: Respecting the Food and Drug Administration - Peter B. Hutt\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Investigation of the Internal Management of the FDA\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Issues Analysis (Empty)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Issues Involving Drug Regulation (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Issues Involving Drug Regulation (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Issues Involving Drug Regulation (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Issues Involving Drug Regulation (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Issues Involving Drug Regulation (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Issues Involving Drug Regulation (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 63 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n IUD\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Japan Background (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Japan Background (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Japan Background (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Japan - 10\/24-30\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Japanese Management\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Jim Turner Issue\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Johnson Memo (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Johnson Memo (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Journal Articles (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Journal Articles (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Kennedy Bills\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Kennedy Hearings (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 64 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Kennedy Hearings (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Larkin, Timothy J. and Alexander M. Schmidt, M.D. - How FDA Regulates Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Larkin, Timothy - Paper - Clinical Trials\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Lasagna, Louis, M.D. - Editor - Controversies in Therapeutics\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Lasker, Mary\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Laws Enforced by the U.S. Food and Drug Administration\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Le Affair Strobel - Ethics\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Legislation - Needs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Legislative Proposals - 4\/21\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Legislative Proposals - Secretary of HEW Forward Plan\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Legislative-Hearings on Cyclamates-Subcommittee No. 2, House Committee. On the Judiciary - 9\/1971\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Letter to Mitzi - Rheumatoid Arthritis\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Letters upon leaving FDA\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 65 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Lincomycin \/ Clindomycin (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Lincomycin \/ Clindomycin (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Linton, Fred B. \u0026quot;Federal Food and Drug Laws: Leaders Who Achieved Their Enactment and Enforcement\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - Advil \/ Motrin (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - Advil \/ Motrin (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - Advil \/ Motrin (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - Advil \/ Motrin (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - Advil \/ Motrin (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - Advil \/ Motrin (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - American Cyanamid Company - Civil Action No. 80-1762\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - American Cyanamid Company - Civil Action No. 80-1762-Addenda\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - American Cyanamid Company - Civil Action No. 80-1762-Correspondence\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - American Cyanamid Company - Civil Action No. 80-1762 - Exhibits\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - American Cyanamid Company - Civil Action No. 80-1762 - Petition for Writ of Mandamus\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - American Cyanamid Company - Initial Decision - Docket No. 75N-0462 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 66 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - American Cyanamid Company - Initial Decision - Docket No. 75N-0462 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - Bupivacaine (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - Bupivacaine (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - Bupivacaine (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - G.D. Searle Cu-7 Cases (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - G.D. Searle Cu-7 Cases (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - The Upjohn Company against American Home Products Corp., and Young \u0026amp; Rubicam, Inc. - 5\/24\/1984\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - The Upjohn Company against American Home Products Corp., and Young \u0026amp; Rubicam, Inc. - 7\/3\/1984\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Litigation - The Upjohn Company against American Home Products Corp., and Young \u0026amp; Rubicam, Inc. - 8\/10\/1984\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Material Sent to the Committee on Nutrition Components\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 67 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n May Meeting - Institute of Medicine - Food and Nutrition Board\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n McAuliffe, William E. \u0026quot;On the Statistical Validity of Standards Used in Profile Monitoring of Health Care.\u0026quot; Harvard School of Public Health: Boston, 1978.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n McCarthy v. G.D. Searle and Company - General Accounting Office Documents (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n McCarthy v. G.D. Searle and Company - General Accounting Office Documents (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n McCarthy v. G.D. Searle and Company - General Accounting Office Documents (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n McCarthy v. G.D. Searle and Company - Plaintiff\u0026#039;s Motion - 9\/23\/1988 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n McCarthy v. G.D. Searle and Company - Plaintiff\u0026#039;s Motion - 9\/23\/1988 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n McCarthy v. G.D. Searle and Company - Plaintiff\u0026#039;s Motion - 9\/23\/1988 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n McCarthy v. G.D. Searle and Company - Plaintiff\u0026#039;s Motion - 9\/23\/1988 (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n MD Dispensing of Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Media\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Center Alumni News, Vol. 37, No. 8, Summer 1982\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Device Amendment Act of 1976 - White House Press Release\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Device Amendments of 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Device Legislation - Revised Information-6\/14\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Device Regulations (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Device Regulations (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 68 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Device Regulations (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Device, Diagnostics \u0026amp; Instrumentation-\u0026quot;The Gray Sheet\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Devices - IUDs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Devices (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Devices (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Devices - Legislation (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Devices - Legislation (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Devices - Pacemakers\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Devices - Safety\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Devices - Sunlamps\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Devices - Toxic Shock\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medicine in the Public Interest, Inc. \u0026quot;Post-Approval Pharmaceutical Research and Development.\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Meetings of Panel on review of viral vaccines, (Open Proceedings), Pages 1-300\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 69 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Meetings of Panel on review of viral vaccines, (Open Proceedings), Pages 301-651\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Merrill, Richard A. and Earl M. Collier, Jr., \u0026quot;\u0026#039;Like Mother Used to Make\u0026#039;: An Analysis of FDA Food Standards of Identity.\u0026quot; Repr. Columbia Law Review, Vol. 74, No. 4, 1974: 561.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Merril, Richard-Risk Benefit Article (with suggested revisions) - March 1977\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Merrill, Richard A. \u0026quot;Compensation for Prescription Drug Injuries.\u0026quot; Repr. Virginia Law Review, Vol. 59, No. 1, 1975.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Meyer, Gerald F. - FDA\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Meyerson, Martin - Biographical Sketch\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Miscellaneous Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Mitchell, Samuel A. and Emery A. Link, eds. \u0026quot;Impact of Public Policy on Drug Innovation and Pricing: Proceedings of the Third Seminar on Pharmaceutical Public Policy Issues.\u0026quot; American University, 1976.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Morris (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 70 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Morris (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Morris, J. Anthony (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Morris, J. Anthony (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Morris, J. Anthony (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n MPAC Seminar - Dimensions of Change\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n N.C. Tox Research [National Center for Toxicological Research] (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n N.C. Tox Research [National Center for Toxicological Research] (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n N.C. Tox Research [National Center for Toxicological Research] (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n N.C. Tox Research [National Center for Toxicological Research] - Morris Cranmer\/Jess Stribling\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n NAS \/ NRC [National Academy of Sciences \/ National Research Council] Conference on Carcinogenesis Testing in the Development of New Drugs (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n NAS \/ NRC [National Academy of Sciences \/ National Research Council] Conference on Carcinogenesis Testing in the Development of New Drugs (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n NAS \/ NRC [National Academy of Sciences \/ National Research Council] Conference on Carcinogenesis Testing in the Development of New Drugs (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n National Academy of Sciences\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 71 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n National Academy of Sciences - A Drug Efficacy Study - Report to the Commissioner of Food and Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n National Academy of Sciences - Institute of Medicine-Food label - Testimony - 12\/4\/1989\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n National Conference on Regulatory Reform - 5\/25-27\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Nelson Hearing - Jolly, etc.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n New England Journal of Medicine, Vol. 292, No. 7, February 13, 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n New England Journal of Medicine, Vol. 304, No. 7, 2\/12\/1981\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n New Orleans - Bureau of Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n New Science (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n New Science (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n News Releases - HEW \/ HHS (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n News Releases - HEW \/ HHS (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Newspaper Clippings\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Notes\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Notes - Miscellaneous\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Novitch, Mark, M.D. - \u0026quot;Dumping or Paternalism? Consumer Groups and U.S. Export Policy\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Nuclear Medicine Imaging\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 72 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Nutrition Components in Food Labeling\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Nutrition Foundation, Inc. \u0026quot;Present Knowledge in Nutrition.\u0026quot; With Supplement, 1953\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Nutrition Labeling, Issues and Directions for the 1990s (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Nutrition Labeling, Issues and Directions for the 1990s (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Nutrition Labeling, Issues and Directions for the 1990s (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Nutrition Labeling, Issues and Directions for the 1990s (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Nutrition Today - Journal - Multiple Issues\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Nutrition - Teaching in Medicine School (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Nutrition - Teaching in Medicine School (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 73 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Nutrition - Teaching in Medicine School (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Obstetrics and Gynecology Advisory Committee Meeting Minutes\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n OC - Office of Professional Consumer Programs - Bill W.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n O\u0026#039;Keefe, Daniel F. and Robert A. Spiegel, eds. \u0026quot;An Analytical Legislative History of the Medical Device Amendments of 1976.\u0026quot; Food and Drug Law Institute Series. Washington, DC, 1976.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Olson, Stanley W. - Regional Medical Program Services Director\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Open Meets\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Organizational Review of the Food and Drug Administration - 12\/10\/1969\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Orphan Drugs (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Orphan Drugs (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Orphan Drugs (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Orphan Drugs - Orphan Drug Products\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Oser, Bernard L., Ph.D. - Exaggerated Conclusions Based on Inadequate Data\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n OTC Drug Evaluation Project - Status Report - 7\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 74 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Overview of Syntex Dog Studies for Enprostil and Its Isomer\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Ozone\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n PA OTC Compilation, 1982 and 1983 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n PA OTC Compilation, 1982 and 1983 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n PA OTC Compilation, 1982 and 1983 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n PA OTC Compilation, 1982 and 1983 (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n PA OTC Compilation, 1982 and 1983 (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n PA OTC, Part I - 6\/1983 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n PA OTC, Part I - 6\/1983 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n PA OTC, Part I - 6\/1983 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Paleolithic Nutrition\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 75 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Panel Discussion on Food and Drug Law Test (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Panel Discussion on Food and Drug Law Test (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Panel Discussion on Food and Drug Law Test (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Panel on Review of Viral Vaccines and Rickettsial Vaccines, (Submission of Report), June 27, 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Participants in the Second Annual Lita Annenberg Hazen Biomedical Workshop - 8\/2-7\/1981\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Patient Package Inserts (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Patient Package Inserts (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Patient Package Inserts (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n PATS: BVM, BMDDP, BB, BRH, NCTR\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n People (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n People (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Percentage Labeling of Foods - 4\/7\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 76 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Personal Type Letters (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Personal Type Letters (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Peter Hutt Writings (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Peter Hutt Writings (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Pharmacists \/ Pharmacy\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Photograph - President Ford and Dr. Schmidt\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Photographs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Photographs and Albums\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Photography \/ Photographic Equipment\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Pictures\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Piel, Gerard - Publisher, Scientific American-\u0026quot;Genetic Engineering\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Plastics (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Plastics (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n PMA [Pharmaceutical Manufacturers Association] Statement on FDA - September 1990\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Policy Board\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 77 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Possible JAMA Editorial (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Possible JAMA Editorial (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescribing Practices\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising (7)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising (8)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising (9)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 78 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising (10)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising to Consumers - Committee Print-September 1984\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising to the consumer: What are the issues?\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising to the consumer: What are the issues? (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drug Advertising to the consumer: What are the issues? (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Prescription Drugs and Health Care-Eli Lilly and Company\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n President Ford to Commissioner Schmidt - Acknowledgement of Resignation - 11\/29\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Proban\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Problem Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Problems in Assessment of Side Effects of New Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Procedural Regulations (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Procedural Regulations (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Procedural Regulations (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 79 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Proceedings-Joint Meeting of World Federation of Proprietary Medicine Manufacturers and the Proprietary Association (U.S.)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Product Liability (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Product Liability (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Progress Report of the Food and Drug Administration, 1984-1988\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Proposals for Amendments to Food, Drug, Cosmetics Act - 5\/27\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Proposed Programs and Organization - Office of Professional and Consumer Programs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Proposed Revision of IND \/ NDA [Investigational New Drug \/ New Drug Application] Regulations - Pharmaceutical Manufacturers Association - 4\/15\/1982 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Proposed Revision of IND \/ NDA [Investigational New Drug \/ New Drug Application] Regulations - Pharmaceutical Manufacturers Association - 4\/15\/1982 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Protection of Human Research Subjects\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Proxmire, William - U.S. Senator - Aspartame\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Public Health News - Indiana State Board of Health\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Public Responsibility Committee - American Cyanamid Company\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Publication Series - The Center for the Study of Drug Development (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Publication Series - The Center for the Study of Drug Development (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Publication Series - The Center for the Study of Drug Development (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 80 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Published Proceedings - \u0026quot;Prescription Drug Advertising to the Consumer: What are the Issues?\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Putting Tea to the Taste\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Radiological Health - Lasers (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Radiological Health - Lasers (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Radiological Health - Lasers (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Radiological Health - Microwave Ovens\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Ralph Stavins - Institute for Policy Studies - Tony Morris Case - 3:30pm\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Read Read Read Read\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Recall\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Recombinant DNA\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Record of Telephone Calls Beginning 8\/20\/75\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Recruit General Counsel\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 81 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Reexamining FDA\u0026#039;s Food Inspectional Strategy - Second Draft\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n References, For Sure (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n References, For Sure (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Regular Correspondence from Commissioner (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Regular Correspondence from Commissioner (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Regulating Carcinogenic Agents in Food\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Regulation of Cancer Causing Food Additives - Time for a Change? - Report to Congress - 12\/11\/1981\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Regulatory Reform (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Regulatory Reform (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Regulatory Reform (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 82 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Regulatory Reform (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Regulatory Reform (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Regulatory Reform (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Regulatory Watch Dog Service - Document 13932 - Joint Commission on Prescription Drug Use, Inc. (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Regulatory Watch Dog Service-Document 13932 - Joint Commission on Prescription Drug Use, Inc. (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Regulatory Watch Dog Service-Document 13932 - Joint Commission on Prescription Drug Use, Inc. (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report of the Commission on Drug Safety, 1964\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report of the Commission on the Federal Drug Approval Process (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report of the Commission on the Federal Drug Approval Process (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report of the Panel on Review of Viral Vaccines and Rickettsial Vaccines, Vol. I, Exhibits 1-13 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 83 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report of the Panel on Review of Viral Vaccines and Rickettsial Vaccines, Vol. I, Exhibits 1-13 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report of the Panel on Review of Viral Vaccines and Rickettsial Vaccines, Vol. I, Exhibits 1-13 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report of the Panel on Review of Viral Vaccines and Rickettsial Vaccines, Vol. I, Exhibits 1-13 (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report of the Panel on Review of Viral Vaccines and Rickettsial Vaccines, Vol. II, Exhibits 14-34 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report of the Panel on Review of Viral Vaccines and Rickettsial Vaccines, Vol. II, Exhibits 14-34 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report of the Panel on Review of Viral Vaccines and Rickettsial Vaccines, Vol. II, Exhibits 14-34 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report of the Temporary Committee for the Review of Data on Carcinogenicity of Cyclamate - 2\/1976 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report of the Temporary Committee for the Review of Data on Carcinogenicity of Cyclamate - 2\/1976 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report of the Temporary Committee for the Review of Data on Carcinogenicity of Cyclamate - 2\/1976 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Report to the Secretary HEW on the Food \u0026amp; Drug Administration by Citizens Advisory Committee - 10\/1962\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Reporting Problem Products to FDA\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Reprint Series - The Center for the Study of Drug Development (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 84 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Reprint Series - The Center for the Study of Drug Development (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Requirements of Laws and Regulations Enforced by the U.S. Food and Drug Administration\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Research (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Research (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Research (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Research (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Research (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Research Fraud\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Reserpine\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Responsible Self-Medication - The Proprietary Association - 1978\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Review Panel on New Drug Regulation\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Revised 1977 Budget Amendment - Medical Devices\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Ricardo-Campbell, Rita. \u0026quot;Risk-Benefit \/ Cost-Benefit: Improving Government Regulation of Approval of New Drugs.\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 85 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Risk Benefit Article\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Ritts Report and David P. Rall Study (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Ritts Report and David P. Rall Study (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Role of the Commissioner\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Rx OTC: New Resources in Self Medication - The Proprietary Association - 11\/1\/1982 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Rx OTC: New Resources in Self Medication - The Proprietary Association - 11\/1\/1982 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Rx OTC: New Resources in Self Medication - The Proprietary Association - 11\/1\/1982 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n S. 510 - \u0026quot;Medical Device Amendments of 1975\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Saccharin (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Saccharin (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Sage, Paul - FDA\u0026#039;s Structure and Function: a Personal View\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n San Francisco District Office Photo Album\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schachtel, Bernard P. - Affidavit - Ibuprofen\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt Deposition in McCarthy v. G.D. Searle and Company, Vol. I, pp. 1-242 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt Deposition in McCarthy v. G.D. Searle and Company, Vol. I, pp. 1-242 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 86 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt Deposition in McCarthy v. G.D. Searle and Company, Vol. I, pp. 1-242 (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt Deposition in McCarthy v. G.D. Searle and Company, Vol. I, pp. 1-242 (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt Deposition in McCarthy v. G.D. Searle and Company, Vol. II, pp. 243-341 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt Deposition in McCarthy v. G.D. Searle and Company, Vol. II, pp. 243-341 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - \u0026quot;The Role of Self Medication\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - \ufffdBy Bread Alone\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - AMS personal correspondence - 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - AMS personal correspondence - 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - AMS personal correspondence - 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - APA and the Food and Drug Administration: An analysis and proposal for action\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - Articles About\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - Bristol-Meyers \/ FTC (Possibly have to testify)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - Commissioner of Food and Drugs - Biographical Sketch\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - Congratulatory Letter to V.P. Ford\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - Critique of Final Term Paper Written by Susan Habakuk\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - Deposition - McCarthy v. G.D. Searle and Company (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - Deposition - McCarthy v. G.D. Searle and Company (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - Deposition - McCarthy v. G.D. Searle and Company (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - Government Service Certificate\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - Interview with Product Management-1\/1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - Meeting with Commissioner of Food and Drugs - 10\/29\/1984\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 87 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - Personal \/ Employment-Related Documents\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - The Commissioner\u0026#039;s Picture Book\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M., M.D. - World Federation of Proprietary Medicine Manufacturers\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M. - Handwritten Notes\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M. - Statement - Congressional Subcommittee Testimony - 1\/20\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M. - Statement-Congressional Subcommittee Testimony - 4\/8\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schmidt, Alexander M. - University of Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Schweiker, Richard S., Secretary HHS - Food and Drug Law Institute - 6\/8\/1981\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Science Court\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Searle Cu-7 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Searle Cu-7 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Searle Cu-7 - Final Report of Investigation of G.D. Searle and Company (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Searle Cu-7 - Final Report of Investigation of G.D. Searle and Company (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Searle Task Force Report (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Searle Task Force Report (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Second General Session, Part 2 - The Proprietary Association\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Secretary\u0026#039;s Panel (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Secretary\u0026#039;s Panel (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 88 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Self-Care and the Consumer - Preliminary Report - The Proprietary Association of Australia\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Self-Medication\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Self-Medication Facts - 1977\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Self-Medication: The New Era\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Senate Subcommittee on Health - Transcript of Proceedings - Intrauterine Devices - The Dalkon Shield - 1\/28\/1975 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Senate Subcommittee on Health - Transcript of Proceedings - Intrauterine Devices - The Dalkon Shield - 1\/28\/1975 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n September 1976 (Empty)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Sidley \u0026amp; Austin (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Sidley \u0026amp; Austin (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Sidley \u0026amp; Austin (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Sidley \u0026amp; Austin (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Sidley \u0026amp; Austin (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Smith, Pye, M.D. - Address Given in 1900\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Social Issues\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Souvenir Program - 14th Annual United Nations Concert and Dinner - 10\/19\/1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 89 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Special Budget Supplemental for Pre-Clinical Testing (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Special Budget Supplemental for Pre-Clinical Testing (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Special Budget Supplemental for Pre-Clinical Testing (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speeches - Miscellaneous\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n St. Louis Chapter of the National Health Federation. \u0026quot;Replace the FDA with an Independent Consumer Protection Agency.\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Standards for Institutional Review Boards for Clinical Investigations\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Studies on Aging\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Study of the Regional Medical Program, Vol. I\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Study of the Regional Medical Program, Vol. II (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Study of the Regional Medical Program, Vol. II (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Study of the Regional Medical Program, Vol. III\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 90 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Subcommittee on Health and the Environment, Committee Print, \u0026quot;Medical Device Legislation-1975\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Subcommittee on National Security and International Operations, Compiled by - \u0026quot;Specialists and Generalists: A Selection of Readings.\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Summary of Recommendations of Prescription Drug Task Force Develop Report (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Summary of Recommendations of Prescription Drug Task Force Develop Report (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Summary of Significant Accomplishments and Activities in Calendar 1986-Supplement - Food and Drug Administration\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Summary of Significant Accomplishments and Activities in Fiscal 1986 - Food and Drug Administration\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Sweeney, John F., Esq.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Symposium on Specification for Food Chemicals - Summary of Proceedings - 3\/13\/1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 91 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit (7)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit - Garay v. Syntex Corp. - Tabs 1-5\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit - Garay v. Syntex Corp. - Tabs 6-7\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit - Garay v. Syntex Corp. - Tab 8\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit - Garay v. Syntex Corp. - Tab 9\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 92 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit - Materials to Hazelton (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit - Materials to Hazelton (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Syntex Lawsuit - Materials to Hazelton (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Task Force on Prescription Drugs, Third Interim Report, \u0026quot;Coverage of Drugs under Medicare,\u0026quot; 1968\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Telecon-Aspartame - 7\/28\/1981\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Testimony\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Testimony on S. 2696 and S. 2697\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Thesis OTC review\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n This is HHS - Brochure - Department of Health \u0026amp; Human Services\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Tommy Austern Writings\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Tony Morris\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Tony Morris - Advanced Notice\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Tony Morris - Correspondence\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Tony Morris - My Response to His\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Tony Morris - Oral Response\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Tony Morris - Tape of Grievance Hearing\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Tony Morris - Written Response\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 93 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Trade Secrets and Patents\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Transfers to the Book Collection\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Travel for 1976 (Empty)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Turtles\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n U.S. Department of Health and Human Services. \u0026quot;Promoting Health\/Preventing Disease: Objectives for the Nation.\u0026quot; Washington, DC, 1980\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n U.S. Department of Health, Education, and Welfare. Office of the Secretary. \u0026quot;Report on the Secretary\u0026#039;s Review Committee of the Task Force on Prescription Drugs.\u0026quot; Washington, DC, 1969\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n U.S. Department of Health, Education, and Welfare. Office of the Secretary. Task Force on Prescription Drugs. \u0026quot;Final Report.\u0026quot; Washington, DC, 1969\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n U.S.-Japan Cooperative Study Program on Health and Welfare\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n United States District Court - Central District of California: In Re G.D. Searle Cu-7 Cases - 3\/9\/1987 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n United States District Court - Central District of California: In Re G.D. Searle Cu-7 Cases - 3\/9\/1987 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n United States District Court - Central District of California: In Re G.D. Searle Cu-7 Cases - 9\/21\/1987 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n United States District Court - Central District of California: In Re G.D. Searle Cu-7 Cases - 9\/21\/1987 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n United States General Accounting Office. \u0026quot;FDA Resources: Comprehensive Assessment of Staffing, Facilities, and Equipment Needed\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Vaccines (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Vaccines (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Vaccines (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 94 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Van Houweling - 5\/30\/1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Van Houweling, Cornelius D., DVM - Bureau of Veterinary Medicine - Johnson Memo\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Van Houweling \/ Kennedy (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Van Houweling \/ Kennedy (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Van Houweling \/ Kennedy (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Van Houweling - Veterinary Medicine (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n Van Houweling - Veterinary Medicine (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Van Vlaanderen, Ed - Self-Medication: Past and Future\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Vitamins (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Vitamins (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 95 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Vitamins and Minerals (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Vitamins and Minerals (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Vitamins and Minerals (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Vitamins and Minerals (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Vitamins and Minerals (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Wall Street Journal\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Washington Drug Letter - 4\/12\/1982\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Waxman \/ Hatch + Testimony\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n We Want You to Know About FDA\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Weinberger et al. v. Hynson, Westcott \u0026amp; Dunning, Inc. Before the Supreme Court of the United States\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n WI-38 Cell Lines\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Wine-Feagan, Patrick\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Wine-Wawszkiewicz, Professor Edward J.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Wodicka, Virgil O., Ph.D. - The Food and Drug Administration Cares About Our Food\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Women\u0026#039;s Evaluation Questionnaire - 101st Annual Meeting-The Proprietary Association\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Working Group for Vet Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Workshop on New Drug Development Policy - Keystone, CO - May 24-27, 1981 (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 96 - General Subject File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Workshop on New Drug Development Policy - Keystone, CO - May 24-27, 1981 (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n World Federation of Proprietary Medicine Manufacturers\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n World Federation of Proprietary Medicine Manufacturers. Partners in Responsible Self Medication-Government Industry \u0026amp; Consumer. Proceedings of the Fifth General Assembly. Sydney, Australia, 1979.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n WSJ [Wall Street Journal]\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Young, Frank E., M.D., Ph.D.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Young, James Harvey - \u0026quot;The Layman\u0026#039;s Hunt for Health: Food, Drugs, and the Environment\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022usa-accordion\u0022 id=\u0022series-content-1222\u0022\u003E\n \u003Cp class=\u0022nara-finding-aids-adv-series-title\u0022\u003E\n \u003Cb\u003ESpeech and Conference File, 1967-90.\u003C\/b\u003E\n \u003C\/p\u003E\n \n \u003Cdiv\u003E\n \u003Cdiv class=\u0022nara-finding-aids-adv-series\u0022\u003E\n \n (Boxes 97-107, 4.8 linear feet)\u003Cbr\/\u003E\n Memoranda, correspondence, press releases, speech drafts, reading copies of speeches, travel documents and receipts, and brochures pertaining primarily to Alexander Schmidt\u0027s speeches on a variety of food and drug-related issues before governmental and private interest groups during his career in the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and in academia. Also included are files for meetings and conferences attended by Schmidt when not making a speech.\u003Cbr\/\u003E\n\u003Cbr\/\u003E\n Arranged chronologically by date of event and alphabetically thereunder.\n \n \u003C\/div\u003E\n \n \n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 97 - Speech and Conference File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 9\/28\/1967 - Orientation of Bureau of Health Manpower Reps. Regional Officers, PHS [Public Health Service]\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1968 - Speeches - Regional Medical Programs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/17-19\/1968 - January Conference - Workshop of Regional Medical Programs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/15\/1968 - Association of Medical Television Broadcasters, UCLA\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 10\/5\/1968 - Annual Meeting of the Association of Hospital Directors of Medical Education-San Antonio, Texas\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 5\/30\/73 - Symposium on Research in Medical Education-Calgary Health Sciences Centre-Alberta, Canada\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 7\/1973 - 6\/1974 - Congressional Testimony (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 7\/1973 - 6\/1974 - Congressional Testimony (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 7\/1973 - 6\/1974 - Congressional Testimony (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 7\/20-22\/1973 - Abraham Lincoln School of Medicine-Chicago, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 8\/2\/1973 - AMA Board of Trustees-Chicago, Illinois (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 8\/2\/1973 - AMA Board of Trustees-Chicago, Illinois (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 8\/2\/1973 - Chicago Regional Office-Chicago, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 8\/15\/1973 - CDC - Atlanta, Georgia\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 9\/13\/1973 - Pharmaceutical Advertising Seminar - Chicago, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 10\/1\/1973 - Tripartite Meeting on Health Matters - Ottawa, Canada\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 10\/16\/1973 - American Baker\u0026#039;s Association - Atlantic City, New Jersey\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 10\/17\/1973 - National Association of Margarine Manufacturers - Washington, DC\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 10\/24\/1973 - Animal Health Institute - Washington, DC\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 11\/13\/1973 - Association of Veterinary Medical Colleges - Washington, DC\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 11\/14-15\/1973 - Leaders in American Medicine - Atlanta, Georgia\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 11\/28\/1973 - Scientific Apparatus Maker\u0026#039;s Association - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/2-3\/1973 - National Center for Toxicological Research - Pine Bluff, Arkansas\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/7\/1973 - American College of Physicians - Houston, Texas\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 98 - Speech and Conference File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/11\/1973 - 16th Annual Meeting of Food and Drug Law Institute - Washington, DC\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/1974 - Speak with Regional Food and Drug Directors \ufffd EDRO [Executive Director of Regional Operations] Conference Room, Rockville, Maryland\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/9\/1974 - American Frozen Food Institute-Informal Gathering - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/17\/1974 - National Conference on Product Recall - New York, New York (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/17\/1974 - National Conference on Product Recall - New York, New York (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/22\/1974 - University of Illinois - Chicago\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/28-29\/1974 - National Canners Association - Atlantic City, New Jersey\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 2\/6\/1974 - Executive Meeting of the National Association of State Departments of Agriculture - Washington DC\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 2\/10-16\/1974 - Japan Trip - Tokyo (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 2\/10-16\/1974 - Japan Trip - Tokyo (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 2\/10-16\/1974 - Japan Trip - Tokyo (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing \u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n open \u003C\/span\u003E\n \n \u003Cspan\u003E\n 7\/10\/1975 - Before the Subcommittee on Health and Subcommittee on Administrative Practice and Procedure\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 10\/20-21\/1975 - Symposium on the Centenary of the United Kingdom Food and Drug Act - London, England\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/14\/1976 - Newsmaker Roundtable Breakfasts - National Press Club, Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/15\/1976 - Martin Luther King - Rockville, Maryland\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 99 - Speech and Conference File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 2\/2\/1976 - Annual Meeting of Health Industry Manufacturers Association - Scottsdale, Arizona\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 2\/3-5\/1976 - Tripartite Meeting - London, England\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 2\/16\/1976 - Consultation at the University of Illinois - Chicago, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 2\/23\/1976 - American Enterprise Institute - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 2\/29-3\/1\/1976 - National Advisory Food and Drug Committee - Pine Bluff, Arkansas\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/1\/1976 - Technical Electronic Product Radiation Safety Standards Committee - Rockville, Maryland\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/4\/1976 - American Pharmaceutical Association - Luncheon - New Orleans, Louisiana\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/22\/1976 - 4th Annual Hans H. Hecht Memorial Lecture - Salt Lake City, Utah\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/28\/1976 - Meet the Commissioner - Philadelphia, Pennsylvania\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 5\/26\/1976 - National Conference on Regulatory Reform - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/4-5\/1976 - National Confectioners Association Annual Meeting - Palm Beach, Florida\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/11\/1976 - 9th Congress of International Federation of Societies of Cosmetic Chemists - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/14\/1976 - Grocery Manufacturers of America-Breakfast with\ufffd - White Sulphur Springs, West Virginia\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/15\/1976 - Conference for Journalists on the Consumer Movement - Watergate Hotel, Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/23-24\/1976 - Association of Food and Drug Officials - Atlanta, Georgia\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/27\/1976 - National Environmental Health Association - Nashville, Tennessee\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 7\/22\/1976 - University of Illinois - Chicago, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 10\/6\/1976 - Mycotoxin Conference - Speech and Dinner - University of Maryland, College Park, Maryland\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 10\/15\/1976 - Chicago Gynecological Society - Chicago, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 11\/3\/1976 - American Pharmaceutical Association Reception - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 11\/4-5\/1976 - Tripartite Meeting - Stone House, Bethesda, Maryland\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/7\/76 - Food and Drug Law Institute - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/15\/1977 - American College of Chest Physicians\u0026#039; Conference on Beta 2 Adrenergic Agents - Scottsdale, Arizona (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 100 - Speech and Conference File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/15\/1977 - American College of Chest Physicians\u0026#039; Conference on Beta 2 Adrenergic Agents - Scottsdale, Arizona (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 2\/9\/1977 - E. F. Hutton Luncheon - Informal Remarks by AMS - Chicago\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/1\/77 - Midwest Committee on Drug Investigation - \u0026quot;Is there a drug in your future?\u0026quot; - Chicago\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/22\/1977 - World Federation of Proprietary Medicine Manufacturers - \u0026quot;The role of self-help medication\u0026quot;- Geneva, Switzerland (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/22\/1977 - World Federation of Proprietary Medicine Manufacturers - \u0026quot;The role of self-help medication\u0026quot; - Geneva, Switzerland (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/22\/1977 - World Federation of Proprietary Medicine Manufacturers - \u0026quot;The role of self-help medication\u0026quot; - Geneva, Switzerland (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/13\/1977 - Lita Bane Memorial Lecture - Urbana, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/26\/1977 - Biomedical Engineering Forum of the AUA - Chicago\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 5\/9\/1977 - Fred W. Tanner Lecture - Chicago Section, Institute of Food Technologists\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/24-25\/1977 - Seminar on Paper and Package Inserts - Panel Discussion - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 7\/22\/1977 - \u0026quot;Food, Drugs, and Cosmetic Safety--who decides? - River Forest Tennis Club - River Forest, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 7\/26\/1977 - Congressional Testimony (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 7\/26\/1977 - Congressional Testimony (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 7\/27\/1977 - AMS Testimony before Kennedy Committee-Washington DC\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 9\/28\/1977 - CIBA GEIGY Symposium - Summit, New Jersey\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 11\/16\/1977 - Oak Party Rotary Club - Oak Park, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 101 - Speech and Conference File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 11\/30\/1977 - Illinois Canners - Champaign, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/13\/1977 - Food and Drug Law Institute - Washington DC\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 2\/15\/1978 - College of Medicine Lectures - University of Iowa Hospital - Iowa City, Iowa\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/6-7\/1978 - Public Symposium on New FDA Proposals to Regulate Medical Device Research - College of Physicians \u0026amp; Surgeons of Columbia University - New York, New York\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/20\/1978 - Indiana Section of the Institute of Food Technologists - Purdue University - West Lafayette, Indiana\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/2\/1978 - Pituitary Symposium - Berkeley, California\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/2\/1978 - After Dinner Speech - Berkeley, California\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 7\/11\/1978 - Drug Regulation Reform Act Conference - George Washington University Club, Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 7\/26\/1978 - \u0026quot;The Role of the Pharmaceutical Industry in Continuing Medical Education\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 8\/2\/1978 - MPAC Summer Seminar - Itasca, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 11\/13\/1978 - PMA Medical Section - Interim Meeting - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/13\/1978-Food and Drug Law Committee of the Chicago Bar Association - Chicago, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/5\/1979 - Pharmaceutical Sciences Section of the American Association for the Advancement of Science - Houston, Texas (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/5\/1979 - Pharmaceutical Sciences Section of the American Association for the Advancement of Science - Houston, Texas (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/11\/1979 - Chancellor\u0026#039;s Advisory Council - Chicago, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/19\/1979 - Midwest Conference on Transcutaneous PO2 Monitoring in Newborn Infants - Chicago, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 5\/13\/1979 - Tony Morris Hearings - Washington, D.C. (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 102 - Speech and Conference File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 5\/13\/1979 - Tony Morris Hearings - Washington, D.C. (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 5\/13\/1979 - Tony Morris Hearings - Washington, D.C. (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 10\/26\/1979 - YMCA \/ YWCA Friday Forum - Urbana, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 10\/31\/1979 - Dowling Lecture - Chicago, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 11\/28\/1979 - Food and Drug Law Committee - Chicago Bar Association - 12:15 p.m.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/12\/1979 - Gardner Speech - Pook\u0026#039;s Hill, Maryland\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/28\/1980 - Background Material for Symposium Speakers and Panelists - The Proprietary Assoc.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/31\/1980 - Self-Medication: The New Era-Symposium - The Proprietary Association\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/25\/1980 - Pharmaceutical Manufacturers Association - Marco Island, Florida\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/31\/1980 - Symposium on Self-Medication - The Proprietary Association - Washington, DC (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/31\/1980 - Symposium on Self-Medication - The Proprietary Association - Washington, DC (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/31\/1980 - Symposium on Self-Medication - The Proprietary Association - Washington, DC (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/31\/1980 - Symposium on Self-Medication - The Proprietary Association - Washington, DC (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 103 - Speech and Conference File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 5\/19-20\/1980 - FDLI - Pharmaceutical Update - Chicago, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/8-9\/1980 - FDLI Annual Banquet - Wahsington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/18\/1981 - Health Industry Manufacturers Association Speech - Scottsdale, Arizona\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/1981 - Regulation and the Drug Industry - Hamilton College, New York\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/10-11\/1981 - Regulation and the Drug Industry - Hamilton College, New York\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 5\/12\/1981 - FDA Anniversary Colloquium - Chicago, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 5\/24\/1981 - New Drugs for the Public Workshop - Keystone, Colorado (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 5\/24\/1981 - New Drugs for the Public Workshop - Keystone, Colorado (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 5\/24-27\/1981 - New Drugs for the Public Workshop - Keystone, Colorado\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/19\/1981 - Illinois Academy of Pediatrics - Chicago - \u0026quot;Drug Regulation: Reagan Style\u0026quot;\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 11\/5\/1981 - National Association of Margarine Manufacturers - Chicago, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/15-16\/1981 - FDLI Annual Educational Conference - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 9\/20\/1982 - Pre-Symposium Speaker\u0026#039;s Meeting - The Proprietary Assoc. - Briefing Book-Arlington, Virginia (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 9\/20\/1982 - Pre-Symposium Speaker\u0026#039;s Meeting - The Proprietary Assoc. - Briefing Book-Arlington, Virginia (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 9\/20\/1982 - Pre-Symposium Speaker\u0026#039;s Meeting - The Proprietary Assoc. - Briefing Book-Arlington, Virginia (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/1982 - Rx to OTC Symposium - The Proprietary Association\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/13\/1982 - Food and Drug Law Institute - Board of Trustees Meeting - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 104 - Speech and Conference File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 1\/26\/1983 - Toxicology Meeting - Midwest Regional Chapter - Society of Toxicology - Northwestern University\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/9-11\/1983 - Rx-OTC Switch Retreat - The Proprietary Association - Palm Beach, Florida (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/9-11\/1983 - Rx-OTC Switch Retreat - The Proprietary Association - Palm Beach, Florida (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/27\/1983 - Leadership Recognition Dinner, Health Sciences Center, Univ. of Illinois - Chicago\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 9\/27\/1983 - Squibb - Princeton, New Jersey\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 4\/30-5\/1\/1984 - Prescription Drug Advertising to the Consumer-Symposium - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/1984 - Pfizer Pharmaceuticals Cardiovascular Medicine Conference\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 10\/26-28\/1984 - Illinois Pharmacists Association - 104th Annual Convention and Exhibition - Peoria, Illinois\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 11\/11-13\/1984 - World Federation of Proprietary Medicine Manufacturers - 7th General Assembly -Tokyo, Japan (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 11\/11-13\/1984 - World Federation of Proprietary Medicine Manufacturers - 7th General Assembly - Tokyo, Japan (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/12\/1984 - 28th Annual Educational Conference - Washington DC\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/12\/1984 - FDLI Annual Educational Conference - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 3\/4\/1985 - Food and Drug Law Institute Seminar on the Legislative Process - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/17\/1985 - Association of Food and Drug Officials - Madison, Wisconsin (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/17\/1985 - Association of Food and Drug Officials - Madison, Wisconsin (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 5\/28\/1986 - Center for the Study of Drug Development Decennial Conference - Boston, MA\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 105 - Speech and Conference File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/23\/1987 - 28th Annual Meeting of the Society of Economic Botany - University of Illinois (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 6\/23\/1987 - 28th Annual Meeting of the Society of Economic Botany - University of Illinois (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/10-11\/1987 - International Society of Regulatory Toxicology and Pharmacology - Arlington, Virginia (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 12\/10-11\/1987 - International Society of Regulatory Toxicology and Pharmacology - Arlington, Virginia (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 2\/10\/1988 - Service Club of Chicago\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 10\/24\/1988 - FDLI 50th Anniversary Project - Washington, DC\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 11\/29-30\/1988 - FDLI 32nd Annual Education Conference - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n 9\/26\/1990 - Institute of Medicine Press Conference - Washington, D.C.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS Speech Drafts (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS Speech Drafts (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n AMS Speech Drafts (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Saved Speeches (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Saved Speeches (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Saved Speeches (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 106 - Speech and Conference File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Saved Speeches (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Saved Speeches (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Saved Speeches (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Saved Speeches (7)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Saved Speeches (8)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speech Material - AMS - Drugs\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speech Material - Regulatory Reform (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speech Material - Regulatory Reform (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speeches (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speeches (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speeches (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speeches (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speeches (5)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speeches (6)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 107 - Speech and Conference File\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speeches by Commissioner (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speeches by Commissioner (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speeches by Commissioner (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Speeches by Commissioner (4)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Undated Speeches\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Up \u0026#039;n Coming Talks, Speeches, etc. (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Up \u0026#039;n Coming Talks, Speeches, etc. (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Up \u0026#039;n Coming Talks, Speeches, etc. (3)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022usa-accordion\u0022 id=\u0022series-content-1223\u0022\u003E\n \u003Cp class=\u0022nara-finding-aids-adv-series-title\u0022\u003E\n \u003Cb\u003EPrinted Material, 1972-85.\u003C\/b\u003E\n \u003C\/p\u003E\n \n \u003Cdiv\u003E\n \u003Cdiv class=\u0022nara-finding-aids-adv-series\u0022\u003E\n \n (Boxes 108-110, 1.3 linear feet)\u003Cbr\/\u003E\n Journals, magazines, and newspapers containing interviews or articles associated with food and drug regulatory policy; the Food and Drug Administration; and the Department of Health, Education, and Welfare, or its successor organization, the Department of Health and Human Services.\u003Cbr\/\u003E\n\u003Cbr\/\u003E\n Arranged alphabetically by publication title.\n \n \u003C\/div\u003E\n \n \n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 108 - Printed Material\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Aesculapius, Vol. 1, No. 3, Spring 1972\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n American Druggist, Vol. 169, No. 9, May 1, 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n American Druggist, Vol. 173, No. 1, January 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n American Druggist, Vol. 175, No. 1, January 1977\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n American Journal of Psychiatry, Vol. 135, No. 9, September 1978\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n American Medical News, August 2, 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Chemical Week, Vol. 113, No. 5, August 1, 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Columbia Law Review, Vol. 74, No. 4, May, 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Consumer Reports, Vol. 42, No. 8, August 1977\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Daedalus: Journal of the American Academy of Arts and Sciences, Vol. 106, No. 1, Winter 1977\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Engineering, Vol. 45, No. 10, October 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Food Processing, Vol. 38, No. 7, July 1977\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Geriatrics, Vol. 28, No. 10, October 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Health Foods Retailing, Vol. XXXVIII, No. 1, January 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hospital Formulary, Vol. 10, No. 11, November 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 109 - Printed Material\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Hospital Formulary, Vol. 11, No. 9, September 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Human Pathology, Vol. 5, No. 3, May 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Tribune and Medical News, Vol. 15, No. 42, November 13, 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Tribune and Medical News, Vol. 16, No. 20, May 28, 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical Tribune and Medical News, Vol. 16, No. 44, December 17, 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical World News, Vol. 14, No. 32, September 7, 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical World News, Vol. 14, No. 37, October 12, 1973\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical World News, Vol. 15, No. 9, March 1, 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical World News, Vol. 16, No. 26, December 1, 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Medical World News, Vol. 17, No. 3, February 9, 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n National Journal Reports (Government Research Corporation), Vol. 7, No. 18, May 8, 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n National Journal Reports (Government Research Corporation), Vol. 7, No. 7, February 15, 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Nutrition Today, Vol. 19, No. 5, September\/October 1984\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Pharmacy Times, Vol 40, No. 5, May 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Pharmacy Times, Vol. 40, No. 6, June 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Pharmacy Times, Vol. 42, No. 3, March 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Private Practice, Vol. 8, No. 11, November 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n PMA Bulletins (1)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n PMA Bulletins (2)\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003Cdetails class=\u0022field field--label-above collapsible-field\u0022 data-once=\u0022details\u0022\u003E\n \u003Csummary class=\u0022field__label\u0022\u003E\n Box 110 - Printed Material\n \u003Cspan class=\u0022summary\u0022\u003E\u003C\/span\u003E\n \u003C\/summary\u003E\n \u003Cdiv class=\u0022field__item\u0022\u003E\n \u003Cdiv\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Private Practice, Vol. 8, No. 12, December 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Resident and Staff Physician, Vol. 20, No. 8, August 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Science, Vol. 191, No. 4226, February 6, 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Science, Vol. 191, No. 4233, March 25, 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Science, Vol. 192, No. 4224, 11 June 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Scroll of Phi Delta Theta, The, Vol. 99, No. 2, Spring 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n The Progressive, Vol. 40, No. 7, 7\/1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n The Sciences, Vol. 21, No. 9, November 1981\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n U.S. Medicine, Vol. 10, No. 2, January 15, 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n U.S. Medicine, Vol. 10, No. 18, September 15, 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n U.S. Medicine, Vol. 10, No. 6, March 15, 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n U.S. Medicine, Vol. 11, No. 1, January 1, 1975\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n U.S. Medicine, Vol. 12, No. 2, January 15, 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n U.S. Medicine, Vol. 12, No. 23, December 1, 1976\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n U.S. News and World Report, Vol LXXVI, No. 14, April 8, 1974\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Verret, Jacqueline and Jean Carper. \u0026quot;Eating May Be Hazardous to Your Health.\u0026quot; Simon and Schuster. New York: ca. 1974.\n \u003C\/span\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022item-listing closed\u0022\u003E\n \u003Cspan class=\u0022item-listing-status\u0022\u003E\n closed \u003C\/span\u003E\n \n \u003Cspan\u003E\n Virginia Journal of Natural Resources Law, Vol. 5, No. 1, Fall 1985\n \u003C\/span\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/details\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\u003C\/div\u003E","settings":null},{"command":"invoke","selector":".ajax-progress","method":"remove","args":[]},{"command":"invoke","selector":".nara-finding-aids-adv-boxes-filter input.button","method":"show","args":[]}]